Montrose Environmental Gr (NYSE:MEG) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.26) by 134.62 percent. This is a 228.57 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $130.31 million which missed the analyst consensus estimate of $142.72 million by 8.69 percent. This is a 1.71 percent decrease over sales of $132.58 million the same period last year.
UPDATE: Montrose Environmental Gr Q3 Adj. EPS $0.09 Beats $(0.26) Estimate
Montrose Environmental Gr (NYSE:MEG) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.26) by 134.62 percent. This is a 228.57 percent increase over losses of $(0.07) per
Related Posts
Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced on Thursday its financial and operational results for the fourth quarter and fiscal year 2024.The company reported a 5% year-over-year increase in revenue to CA$67.4 million ($49.1 million) in the fourth quarter. Global medical cannabis net revenue grew by 20% over the same period to CA$45.6 million. The increase in net revenue1 of $7.7 million was primarily due to higher sales to Australia and Europe in the current period following the success of newly launched innovative cultivars in these markets.
Janney Montgomery Scott Downgrades Lakeland Bancorp to Neutral
Janney Montgomery Scott analyst Jake Civiello downgrades Lakeland Bancorp (NASDAQ:LBAI) from Buy to Neutral.
Akoya Biosciences Marks Milestone Achievement With Shipment Of 1,000th Spatial Biology Instrument
Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company®, today announced it has shipped it's 1,000th instrument, a significant milestone for the company and the largest